[Balloon dilatation of the pulmonary valve. Short-, middle- and long-term results]

G Buheitel1, B Böhm, A Koch

  • 1Abteilung Pädiatrische Kardiologie Klinik mit Poliklinik für Kinder und Jugendliche, Friedrich-Alexander Universität Erlangen-Nürnberg. Gernot.Buheitel@Kinder.imed.uni-erlangen.de

Zeitschrift Fur Kardiologie
|August 23, 2001
PubMed

Insights

Balloon dilatation effectively treats pulmonary valve stenosis, significantly reducing pressure gradients. This procedure is safe and offers lasting results, particularly for typical and critical cases in infants.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Background:

  • Pulmonary valve stenosis (PVS) is a significant congenital heart defect.
  • Effective treatment options for PVS are crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the immediate and long-term efficacy of balloon dilatation for pulmonary valve stenosis.
  • To assess the safety and outcomes across different types of PVS.

Main Methods:

  • Retrospective analysis of 111 patients (1 day-18 years) undergoing pulmonary valve balloon dilatation.
  • Patients categorized into four groups: typical PVS, dysplastic PVS, critical PVS, and pulmonary atresia.
  • Exclusion of patients with complex congenital heart disease.

Main Results:

  • Average systolic transvalvular gradient reduced by 60% (68.5 to 27.2 mmHg) post-procedure.
  • 80% of patients achieved sufficient treatment via transcatheter balloon dilatation.
  • High success rates observed in typical and critical PVS groups, with fewer benefits in dysplastic PVS and pulmonary atresia.

Conclusions:

  • Balloon dilatation is a secure and effective treatment for pulmonary valve stenosis.
  • Optimal outcomes are achieved in typical PVS and critical PVS in newborns/infants.
  • The procedure demonstrates a low rate of major complications (7.3%) with no lasting residuals or deaths.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...